Biotech · Private company
Alpha Tau Medical LTD.
Track this companyFree. Adds Alpha Tau Medical LTD. to your Dealase workspace and tells you when its record changes.
Clinical trials54 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- DaRT seedsRecurrent Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- DaRT seedsSquamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Device :DaRT seedsRecurrent GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Diffusing Alpha-emitter Radiation TherapyMalignant Skin TumorClinicalTrials.gov · fetched Nov 12, 2026
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised PatientsNA · RECRUITING · started Jan 1, 2026ClinicalTrials.gov NCT06615635 · fetched Nov 12, 2026
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaNA · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT06910306 · fetched Nov 12, 2026
- Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerNA · ACTIVE_NOT_RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT06698458 · fetched Nov 12, 2026
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell CarcinomaNA · ACTIVE_NOT_RECRUITING · started Sep 21, 2022ClinicalTrials.gov NCT05323253 · fetched Nov 12, 2026
- Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue TumorsNA · COMPLETED · started Jan 6, 2020ClinicalTrials.gov NCT04377360 · fetched Nov 12, 2026